Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.


CSE:BETR - Post by User

Comment by CannabisBearon Oct 02, 2020 10:57am
127 Views
Post# 31657623

RE:RE:RE:RE:Pump and dump scam here.

RE:RE:RE:RE:Pump and dump scam here.thanks for your wisdom.  I really didnt want to reply but its friday and I am coming off a great week $$$$ in the market and the trump news means next week will even better. 

Spoke to my experienced pharma investor buddies and here it goes.

I would like to point out that imho there is no chance whatsoever of recruiting sufficient enough patients to execute the planned trial in AUSTRALIA at this time.....unless the 24 new cases per day in that country as of yesterday is your best gameplan.  find a sexier country where COVID is on fire. 

maybe the goal is to float a country that enters summer (and few new cases of COVID trickling in) and drag this one out for 3 years to slow walk this thing...or CEO thinks AUS is close enough to China where he can repeat another enectdotal study in Wuhan that nobody really takes seriously.  
 

**how about laying the groundwork for a serious development plan for your shareholders and executing to it with newsflow; while getting that terrible website pharma therapeutice etc (x2) cleaned up and especially remove that terrible corporate slide deck. its just sloppy like the gantt chart in it.  

if your an insider or sleeping next to one, you may want to find a new angle to sword fight with people way more skilled than you. 
<< Previous
Bullboard Posts
Next >>